"The study, which has received IND clearance by the FDA and is...

"The study, which has received IND clearance by the FDA and is expected to open to enrollment by year end 2023"

It seems that the trial is recruiting patients now:


https://clinicaltrials.gov/study/NCT05834244

Whilst the status has been updated on 26/10/23, the company announcement above dated 20/11/23 suggested it hasn't at that time.

I found the following link to apply for the trial:



https://www.withpower.com/trial/phase-1-leukemia-8-2023-2f24f

The ASH poster can be found here:
https://ash.confex.com/ash/2023/webprogram/Paper182885.html



A comment from PI Dr Abhishek Maiti:
"Furthermore, this clinical trial can potentially transform the standard treatment approach as well as landscape of emerging therapies for older, unfit, or transplant-ineligible patients."
https://gatewaycr.org/for-researchers/clinical-trials/azacitidine-venetoclax-and-nk-cells-in-newly-daignosed-older-unfit-aml/